Bifogade filer
Beskrivning
Land | Norge |
---|---|
Lista | Euronext Growth Oslo |
Sektor | Hälsovård |
Industri | Medicinteknik |
2025-08-26 14:35:51
Reference is made to SoftOx's press release dated 14 August 2025 concerning the
Equity Placement Facility Agreement with Long State Investments Ltd. ("Long
State"). Certain shareholders, referred to as the Lending Shareholders, have
entered into a share loan agreement (the "Agreement") with Long State. This
Agreement facilitates the lending of shares in SoftOx as part of the financing
facility, whereby certain shareholders will lend a total of 60 000 000 shares to
Long State over a period of 24 months from the start of the Equity Facility
Placement Agreement, unless extended in accordance with its terms.
The lending shareholders will not receive any compensation for lending shares to
Long State. However, SoftOx will reimburse them for documented expenses incurred
by banks or brokers related to transactions executed as a result of this loan
agreement.
The lending shareholders include the following primary insiders:
Sporcon Lifescience Advisors ApS, a company controlled by COB Ulrik Spork, has
agreed to lend Long State 30 000 000 shares under the Agreement. In addition to
the loaned shares, Sporcon Lifescience Advisors ApS holds 714 285 shares in
SoftOx.
Thomas Bjarnsholt Holding ApS, a company controlled by CEO Thomas Bjarnsholt,
has agreed to lend Long State 11 000 000 shares under the Agreement. In addition
to the loaned shares, Thomas Bjarnsholt Holding ApS holds 470 574 shares in
SoftOx.
Bonica AS, a company controlled by CFO Ingrid Juven, has agreed to lend Long
State 5 000 000 shares under the Agreement. In addition to the loaned shares,
Bonica AS holds 80 000 000 shares in SoftOx.
Enclosed with this announcement is the notification of transactions conducted by
individuals with managerial responsibilities and their closely associated
persons, in compliance with Regulation (EU) 2016/523.